Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways

British Journal of Cancer

Volumn 103, Issue 8, 2010, Pages 1255-1262

  Sitaram, R T ^a   Degerman, S ^a   Ljungberg, B ^a   Andersson, E ^a   Oji, Y ^b   Sugiyama, H ^b   Roos, G ^a   Li, A ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

hTERT; renal cell carcinoma; telomerase activity and pathways; WT1

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 1; MYC PROTEIN; SMAD3 PROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETS 1; PROTEIN BINDING; TERT PROTEIN, HUMAN; WT1 PROTEIN;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY CORTEX; NEPHROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; TUMOR SUPPRESSOR GENE; DOWN REGULATION; ENZYME ACTIVATION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; KIDNEY TUMOR; METABOLISM; ONCOGENE MYC; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DOWN-REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; HUMANS; KIDNEY NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SIGNAL TRANSDUCTION; TELOMERASE; TRANSFECTION; WT1 PROTEINS;

EID: 77957988663     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605878     Document Type: Article

References (49)

1. Ariyaratana S, Loeb DM (2007) The role of the Wilms' tumour gene (WT1) in normal and malignant haematopoiesis. Expert Rev Mol Med 9: 1-17
2. Bellon M, Nicot C (2008) Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 112: 2946-2955
3. Bruening W, Moffett P, Chia S, Heinrich G, Pelletier J (1996) Identification of nuclear localization signals within the zinc fingers of the WT1 tumor suppressor gene product. FEBS Lett 393: 41-47
4. Burwell EA, McCarty GP, Simpson LA, Thompson KA, Loeb DM (2007) Isoforms of Wilms' tumor suppressor gene (WT1) have distinct effects on mammary epithelial cells. Oncogene 26: 3423-3430
5. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520
6. Campbell CE, Kuriyan NP, Rackley RR, Caulfield MJ, Tubbs R, Finke J, Williams BR (1998) Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int J Cancer 78: 182-188
7. Chatagnon A, Bougel S, Perriaud L, Lachuer J, Benhattar J, Dante R (2009) Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells. Carcinogenesis 30: 28-34
8. Committe TNWTS (1991) Wilms' tumour: status report 1990. J Clin Oncol 9: 877-887
9. Cukusic A, Skrobot Vidacek N, Sopta M, Rubelj I (2008) Telomerase regulation at the crossroads of cell fate. Cytogenet Genome Res 122: 263-272
10. Degerman S, Siwicki JK, Osterman P, Lafferty-Whyte K, Nicol Keith W, Roos G (2010) Telomerase upregulation is a postcrisis event during senescence bypass and immortalization of two Nijmegen breakage syndrome T cell cultures. Aging Cell 9: 220-235
11. Deng WG, Jayachandran G, Wu G, Xu K, Roth JA, Ji L (2007) Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. J Biol Chem 282: 26460-26470
12. Devereux TR, Horikawa I, Anna CH, Annab LA, Afshari CA, Barrett JC (1999) DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. Cancer Res 59: 6087-6090 (Pubitemid 30035625)
13. Dwyer J, Li H, Xu D, Liu JP (2007) Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann N Y Acad Sci 1114: 36-47
14. Gewin L, Myers H, Kiyono T, Galloway DA (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 18: 2269-2282
15. Greene FL, Sobin LH (2002) The TNM system: our language for cancer care. J Surg Oncol 80: 119-120
16. Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE (1990) An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell 61: 1257-1269
17. Haber DA, Englert C, Maheswaran S (1996) Functional properties of WT1. Med Pediatr Oncol 27: 453-455
18. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88: 9618-9622 (Pubitemid 21915682)
19. Han Y, San-Marina S, Liu J, Minden MD (2004) Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene 23: 6933-6941
20. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T (1993) Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259: 971-974
21. Hattori K, Angel P, Le Beau MM, Karin M (1988) Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci USA 85: 9148-9152
22. Hewitt SM, Hamada S, McDonnell TJ, Rauscher III FJ, Saunders GF (1995) Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res 55: 5386-5389
23. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89: 1405-1412
24. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, Nakazawa T, Tatsumi N, Sakaguchi N, Takashima S, Shirakata T, Nishida S, Hosen N, Kawakami M, Tsuboi A, Oka Y, Itoh K, Sugiyama H (2006) Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97: 259-270
25. Kim HS, Kim MS, Hancock AL, Harper JC, Park JY, Poy G, Perantoni AO, Cam M, Malik K, Lee SB (2007) Identification of novel Wilms' tumor suppressor gene target genes implicated in kidney development. J Biol Chem 282: 16278-16287
26. Kovacs G (1996) Molecular genetics of human renal cell tumours. Nephrol Dial Transplant 11(Suppl 6): 62-65
27. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, van den Berg E, Zbar B (1997) The Heidelberg classification of renal cell tumours. J Pathol 183: 131-133
28. Lacerte A, Korah J, Roy M, Yang XJ, Lemay S, Lebrun JJ (2008) Transforming growth factor-beta inhibits telomerase through SMAD3 and E2F transcription factors. Cell Signal 20: 50-59
29. Lee SH, Kim JW, Lee HW, Cho YS, Oh SH, Kim YJ, Jung CH, Zhang W, Lee JH (2003) Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression. Oncogene 22: 381-391
30. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S (2001) Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. Cancer Res 61: 921-925
31. Ma H, Urquidi V, Wong J, Kleeman J, Goodison S (2003) Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells. Mol Cancer Res 1: 739-746
32. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE, Haber DA (1993) Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90: 5100-5104
33. Mano Y, Shimizu T, Tanuma S, Takeda K (2000) Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells. Anticancer Res 20: 1649-1652
34. Nakatsuka S, Oji Y, Horiuchi T, Kanda T, Kitagawa M, Takeuchi T, Kawano K, Kuwae Y, Yamauchi A, Okumura M, Kitamura Y, Oka Y, Kawase I, Sugiyama H, Aozasa K (2006) Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol 19: 804-814
35. Niu Z, Ito M, Awakura Y, Takahashi T, Nakamura E, Ito N., Ogawa O (2005) The expression of NOV and WT1 in renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis. J Urol 174: 1460-1462
36. Oh S, Song Y, Yim J, Kim TK (1999) The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcrip-tase gene. J Biol Chem 274: 37473-37478
37. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Sugiyama H (2002) Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100: 297-303
38. Rong Y, Cheng L, Ning H, Zou J, Zhang Y, Xu F, Liu L, Chang Z, Fu XY (2006) Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res 66: 8049-8057
39. Scharnhorst V, van der Eb AJ, Jochemsen AG (2001) WT1 proteins: functions in growth and differentiation. Gene 273: 141-161
40. Sitaram RT, Cairney CJ, Grabowski P, Keith WN, Hallberg B, Ljungberg B, Roos G (2009) The PTEN regulator DJ-1 is associated with hTERT expression in clear cell renal cell carcinoma. Int J Cancer 125: 783-790
41. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28: 1165-1177
42. Takakura M, Kyo S, Inoue M, Wright WE, Shay JW (2005) Function of AP-1 in transcription of the telomerase reverse transcriptase gene (TERT) in human and mouse cells. Mol Cell Biol 25: 8037-8043
43. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 59: 551-557
44. Ueda T, Oji Y, Naka N, Nakano Y, Takahashi E, Koga S, Asada M, Ikeba A, Nakatsuka S, Abeno S, Hosen N, Tomita Y, Aozasa K, Tamai N, Myoui A, Yoshikawa H, Sugiyama H (2003) Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas. Cancer Sci 94: 271-276
45. Wagner N, Michiels JF, Schedl A, Wagner KD (2008) The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo. Oncogene 27: 3662-3672
46. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R (1999) Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224
47. Xiao X, Athanasiou M, Sidorov IA, Horikawa I, Cremona G, Blair D, Barret JC, Dimitrov DS (2003) Role of Ets/Id proteins for telomerase regulation in human cancer cells. Exp Mol Pathol 75: 238-247
48. Yang L, Han Y, Suarez Saiz F, Minden MD (2007) A tumor suppressor and oncogene: the WT1 story. Leukemia 21: 868-876
49. Ye Y, Raychaudhuri B, Gurney A, Campbell CE, Williams BR (1996) Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. Embo J 15: 5606-5615